Phase 2 Cognitive Impairment Clinical Trials

48 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 120 of 48 trials

Recruiting
Phase 2

CBD for Individuals at Risk for Alzheimer's Disease

Mild Cognitive Impairment
University of Colorado, Denver236 enrolled1 locationNCT05822362
Recruiting
Phase 2

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Massachusetts General Hospital40 enrolled1 locationNCT07236190
Recruiting
Phase 2

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Mild Cognitive ImpairmentEarly Alzheimer's DiseaseAD-MCI
Bernard (Barry) Baumel10 enrolled1 locationNCT07512362
Recruiting
Phase 2

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Weill Medical College of Cornell University20 enrolled1 locationNCT07553338
Recruiting
Phase 2

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Mild Cognitive ImpairmentAmnestic Mild Cognitive ImpairmentAmnestic Mild Cognitive Disorder+2 more
University of Texas Southwestern Medical Center75 enrolled1 locationNCT05446584
Recruiting
Phase 2

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

Breast CancerBreast Cancer Stage IBreast Cancer Stage II+5 more
UNC Lineberger Comprehensive Cancer Center90 enrolled1 locationNCT06727773
Recruiting
Phase 1Phase 2

rTMS to Improve Cognition in Parkinson's

Mild Cognitive ImpairmentParkinson's Disease
VA Office of Research and Development56 enrolled2 locationsNCT03836950
Recruiting
Phase 2

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

DementiaHealthy VolunteersAlzheimer Disease+1 more
Akiva Mintz200 enrolled1 locationNCT07012993
Recruiting
Phase 2

Novel Augmentation of DAOIB and Antioxidant for Early Dementia

Alzheimer DiseaseMild Cognitive Impairment
Chang Gung Memorial Hospital80 enrolled1 locationNCT06467539
Recruiting
Phase 1Phase 2

Sense4Safety Intervention

Mild Cognitive Impairment
University of Pennsylvania200 enrolled1 locationNCT07220668
Recruiting
Phase 2

Repurposing Siponimod for Alzheimer's Disease

Alzheimer DiseaseCognitive Impairment, MildMild Alzheimer Disease+1 more
St. Joseph's Hospital and Medical Center, Phoenix105 enrolled1 locationNCT06639282
Recruiting
Phase 2

Cognitive Remediation Intervention to Prepare for Transition of Care

Cognitive ImpairmentSickle Cell DiseaseSelf Efficacy+3 more
University of Alabama at Birmingham120 enrolled1 locationNCT05336201
Recruiting
Phase 2

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

DementiaAlzheimers DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Brigham and Women's Hospital16 enrolled1 locationNCT06489548
Recruiting
Phase 1Phase 2

The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment

ElderlyMild Cognitive ImpairmentOverweight or Obesity
Fudan University54 enrolled1 locationNCT07395960
Recruiting
Phase 2

Senicapoc in Alzheimer's Disease

Alzheimer DiseaseMild Cognitive Impairment
University of California, Davis55 enrolled2 locationsNCT04804241
Recruiting
Phase 2

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

FrailtyAgingMild Cognitive Impairment
UConn Health60 enrolled1 locationNCT06027554
Recruiting
Phase 1Phase 2

Living Independence Through Functional Training

Cognitive ImpairmentMobility Limitation
University of Florida10 enrolled2 locationsNCT07125378
Recruiting
Phase 2

Study of ALTO-101 in Patients With Schizophrenia

Cognitive ImpairmentSchizophrenia
Alto Neuroscience82 enrolled14 locationsNCT06502964
Recruiting
Phase 2

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Mild Cognitive Impairment (MCI)Cognitive Training
Columbia University240 enrolled4 locationsNCT06601933
Recruiting
Phase 2

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Cognitive Impairment Associated With Schizophrenia (CIAS)
Kynexis B.V.150 enrolled13 locationsNCT07191483